1. Home
  2. NTRA vs TYL Comparison

NTRA vs TYL Comparison

Compare NTRA & TYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$244.06

Market Cap

27.0B

Sector

Health Care

ML Signal

HOLD

Logo Tyler Technologies Inc.

TYL

Tyler Technologies Inc.

HOLD

Current Price

$468.39

Market Cap

20.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
NTRA
TYL
Founded
2003
1966
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
27.0B
20.2B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
NTRA
TYL
Price
$244.06
$468.39
Analyst Decision
Strong Buy
Buy
Analyst Count
16
9
Target Price
$227.69
$666.78
AVG Volume (30 Days)
1.7M
378.0K
Earning Date
11-06-2025
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
31.32
EPS
N/A
7.19
Revenue
$2,116,676,000.00
$2,298,292,000.00
Revenue This Year
$32.77
$10.96
Revenue Next Year
$16.51
$8.90
P/E Ratio
N/A
$65.26
Revenue Growth
38.17
10.62
52 Week Low
$125.38
$450.00
52 Week High
$245.59
$661.31

Technical Indicators

Market Signals
Indicator
NTRA
TYL
Relative Strength Index (RSI) 80.03 47.17
Support Level $233.67 $460.60
Resistance Level $240.18 $469.29
Average True Range (ATR) 7.39 9.94
MACD 0.68 2.01
Stochastic Oscillator 97.49 57.34

Price Performance

Historical Comparison
NTRA
TYL

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About TYL Tyler Technologies Inc.

Tyler Technologies provides a full suite of software solutions and services that address the needs of cities, counties, schools, courts and other local government entities. The company's three core products are Munis, which is the core ERP system, Odyssey, which is the court management system, or CMS, and payments. The company also provides a variety of add-on modules and offers outsourced property tax assessment services.

Share on Social Networks: